Bartlett & CO. Wealth Management LLC Has $1.35 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Bartlett & CO. Wealth Management LLC lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,277 shares of the financial services provider’s stock after selling 237 shares during the period. Bartlett & CO. Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,351,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Future Financial Wealth Managment LLC bought a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at $27,000. Bbjs Financial Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the second quarter worth about $31,000. Pacifica Partners Inc. lifted its holdings in shares of iShares Biotechnology ETF by 118.2% during the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 130 shares in the last quarter. Mather Group LLC. bought a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at about $57,000. Finally, Chris Bulman Inc acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $64,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.2 %

Shares of IBB opened at $145.91 on Friday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57. The firm’s 50 day moving average price is $145.65 and its two-hundred day moving average price is $139.69.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.